Tirzepatide, sold under the brand names Mounjaro (for type 2 diabetes) and Zepbound (for obesity), is one of the most clinically significant medications to enter the weight management space in decades. As a dual GIP and GLP-1 receptor agonist, it targets two hormone pathways simultaneously, producing weight loss outcomes that have reached up to 22 percent of total body weight in clinical trials. For many patients, knowing how to use tirzepatide at home safely is the first pra

A Note Before You Begin Weight loss injections have become one of the most searched health topics of the past three years, and for good reason. GLP-1 receptor agonists such as semaglutide and tirzepatide have delivered clinical results that were once considered impossible without surgery: 15 to 22 percent total body weight loss in randomised controlled trials, with meaningful improvements in blood sugar, blood pressure, and cardiovascular risk markers. The surge in demand has

If you're considering Tirzepatide as part of your weight loss journey, or have just started your first few doses, you might be wondering...